Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04492800 · ClinicalTrials.gov registry record · NA

Hair Loss Prevention Study for Pancreatic Cancer

A NA study, sponsored by HonorHealth Research Institute.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT04492800 is a NA study that has completed, run by HonorHealth Research Institute. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04492800, a NA study, has completed, sponsored by HonorHealth Research Institute.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.

Interventions

  • DEVICE Paxman Scalp Cooling Device

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2019-12-13
Est. Completion 2021-12-31
Phase NA

Sponsor

HonorHealth Research Institute

20 total trials

What the Registry Record Tells You About NCT04492800

The ClinicalTrials.gov registry entry for NCT04492800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HonorHealth Research Institute, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Paxman Scalp Cooling Device is the first listed.

NCT04492800 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04492800 about?

NCT04492800 is a clinical study titled "Hair Loss Prevention Study for Pancreatic Cancer". Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.

What is the current status of trial NCT04492800?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-12-13. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT04492800?

The interventions under investigation include: Paxman Scalp Cooling Device (DEVICE).

Who is sponsoring clinical trial NCT04492800?

This trial is sponsored by HonorHealth Research Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.